Correlation Between Intel and Phoenix Biotech
Can any of the company-specific risk be diversified away by investing in both Intel and Phoenix Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intel and Phoenix Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intel and Phoenix Biotech Acquisition, you can compare the effects of market volatilities on Intel and Phoenix Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intel with a short position of Phoenix Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intel and Phoenix Biotech.
Diversification Opportunities for Intel and Phoenix Biotech
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Intel and Phoenix is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Intel and Phoenix Biotech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phoenix Biotech Acqu and Intel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intel are associated (or correlated) with Phoenix Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phoenix Biotech Acqu has no effect on the direction of Intel i.e., Intel and Phoenix Biotech go up and down completely randomly.
Pair Corralation between Intel and Phoenix Biotech
If you would invest 1,938 in Intel on December 5, 2024 and sell it today you would earn a total of 195.00 from holding Intel or generate 10.06% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Intel vs. Phoenix Biotech Acquisition
Performance |
Timeline |
Intel |
Phoenix Biotech Acqu |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Intel and Phoenix Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Intel and Phoenix Biotech
The main advantage of trading using opposite Intel and Phoenix Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intel position performs unexpectedly, Phoenix Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phoenix Biotech will offset losses from the drop in Phoenix Biotech's long position.Intel vs. ASE Industrial Holding | Intel vs. United Microelectronics | Intel vs. MaxLinear | Intel vs. SemiLEDS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |